If there's a biological problem, there's a biological solution.

Our Mission & Technology

The majority of everyday drugstore products—soap, shampoo, lotion, etc.—contain chemicals that are banned or soon-to-be-banned by the FDA. Curie Co makes 100% sustainable and safe ingredients from recycled marine biomaterials (branded OceanSafe™) for use in 100s of products you can find on the shelves of Walmart, Target and CVS—all without inflating their price points.

With a powerful combination of synthetic biology and enzyme engineering, Curie Co’s new materials can fully replace the function of the banned chemicals. So when used in existing consumer products, they will work to the same effect. These solutions are biocompatible for consumers and environment alike: safe on humans, with no harm to our oceans. Curie Co has partnered with national labs and academic institutions—in addition to being a JLABS company—to develop a new generation of antimicrobial compounds and preservatives.

Curie Co’s mission is to replace chemicals banned by the FDA with OceanSafe™ ingredients in everyday goods, so consumers can get their same favorite products, at the same price point, without doing harm to the environment or themselves. To this end, Curie Co is positioned to become a trusted supplier and world leader of engineered enzymes and biopolymers.

They’re specifically targeting those that go down the drain because they end up in our waterways where they can’t break down, causing negative impact on aquatic life and human health. At present, manufacturers have few alternatives to these preservatives.

Curie Co’s OceanSafe™ recycled marine biomaterials will replace these harmful chemicals in common consumer products—and more. They can be used to replace preservatives or create new biodegradable bioplastics for microbeads, packaging, and films.

2015—

Congress enacted into law a ban on non-biodegradable microbeads due to their devastating effect on our oceans.

2016—

The FDA eliminated 19 chemicals found in consumer soaps by banning antibacterial soaps.

2017—

The FDA further banned 23 chemicals in clinical soaps, such as surgical scrubs.

2018—

Personal Care Products Act was assigned to committee in Congress to give the FDA jurisdiction over the personal care industry.

Curie Co’s Solution

Curie Co’s propriety OceanSafe™ technology uses enzyme engineering and recycled marine biomaterials to completely replace these FDA-banned chemicals. Our 100% sustainable and safe ingredients can be washed down the drain with no threat to our waterways. Even better—they’re affordable enough for drugstore brands and products.

Uses for Curie Co Bioplastic

preservatives

As found in shampoos, soaps, face washes, lotions, sunscreens, cosmetics, and 100s of other personal care products.

BioPlastics

First aid

Ointments, wound care, and disease prevention that are naturally antimicrobial to keep infection at bay. Bonus: Our materials are affordable enough that they won’t burden the massive healthcare industry.

OceanSafe™

OceanSafe™

Consumers are becoming increasingly ingredient-conscious and label-literate. More than ever, shoppers are checking their personal care products for lists of chemicals (or lack thereof), testing ethics, and sustainability.

Products made with Curie Co’s 100% sustainable and safe ingredients will be able to carry our branded OceanSafe™ label so consumers can see—quickly and clearly—that they’re making a smart, healthy purchase for their loved ones and themselves.

Meet the Team

Our team has a strong IP track record in enzyme engineering for FDA-regulated industries. The team has scientific expertise in pharmaceutical manufacturing, industrial enzyme engineering, and bioinformatics.

Dr. Erika Milczek, Chief Executive Officer and Founder

After completing a doctoral work at Emory University and a postdoctoral fellowship at Princeton University, Dr. Milczek joined Merck & Co as a Senior Process Chemist in the Biocatalysis Group. While at Merck, she replaced chemical manufacturing processes with enzymatic routes for commercial drug synthesis.

Ken Mitchell, Chief Operations Officer

Mr. Mitchell is a scientific and business strategy consultant with 20 years of enzyme engineering experience. He has been on the ground floor of establishing enzyme engineering technologies at Maxygen and Codexis. Mr. Mitchell was the Founder and Chief Executive Officer at Gene Oracle, Inc. and Founder and Chief Executive Officer at Aligna Technologies, Inc.

Kristyn Merritt, Chief Creative Officer

With over 15 years of brand identity development, content strategy, copywriting, and editorial experience, Ms. Merritt has helped create voices for some of the largest names in media and marketing. She has worked for NBC/Universal, Birchbox, Nickelodeon, AOL, and Hearst Magazines, and consulted with dozens of other brands — all with a focus on female demographics.

Dr. Valarie Truax, Advisor

Dr. Truax has over 15 years of experience in IP licensing and Biotechnology/Healthcare M&A. Dr. Truax has an MBD and PhD in chemistry and has worked at both the Office of Cooperative Research at Yale University and Madison Keats.